128 related articles for article (PubMed ID: 23303566)
21. Contribution of the fibrinolytic pathway to hematopoietic regeneration.
Heissig B; Ohki M; Ishihara M; Tashiro Y; Nishida C; Gritli I; Rosenkvist J; Hattori K
J Cell Physiol; 2009 Dec; 221(3):521-5. PubMed ID: 19681053
[TBL] [Abstract][Full Text] [Related]
22. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
[TBL] [Abstract][Full Text] [Related]
23. Binding and activation of plasminogen on the surface of osteosarcoma cells.
Campbell PG; Wines K; Yanosick TB; Novak JF
J Cell Physiol; 1994 Apr; 159(1):1-10. PubMed ID: 7511144
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients.
Thaler J; Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463
[TBL] [Abstract][Full Text] [Related]
25. Procoagulant microparticles: disrupting the vascular homeostasis equation?
Morel O; Toti F; Hugel B; Bakouboula B; Camoin-Jau L; Dignat-George F; Freyssinet JM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2594-604. PubMed ID: 16990554
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles.
Fogli S; Neri T; Nuti E; Mattii L; Camodeca C; Rossello A
Pharmacol Rep; 2019 Jun; 71(3):485-490. PubMed ID: 31005034
[TBL] [Abstract][Full Text] [Related]
27. [Clinical and etiopathogenetic role of plasminogen and metaloproteinase systems in the tumor growth. Pericellular proteolysis of extracellular matrix and tumor growth].
Cosić SJ; Kovac Z
Lijec Vjesn; 2011; 133(1-2):56-63. PubMed ID: 21644280
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
29. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction.
Habersberger J; Strang F; Scheichl A; Htun N; Bassler N; Merivirta RM; Diehl P; Krippner G; Meikle P; Eisenhardt SU; Meredith I; Peter K
Cardiovasc Res; 2012 Oct; 96(1):64-72. PubMed ID: 22798388
[TBL] [Abstract][Full Text] [Related]
30. Matrikines in the regulation of extracellular matrix degradation.
Maquart FX; Bellon G; Pasco S; Monboisse JC
Biochimie; 2005; 87(3-4):353-60. PubMed ID: 15781322
[TBL] [Abstract][Full Text] [Related]
31. Binding and activation of plasminogen at the surface of human keratinocytes.
Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
[TBL] [Abstract][Full Text] [Related]
32. Microparticles in cancer: A review of recent developments and the potential for clinical application.
Gong J; Jaiswal R; Dalla P; Luk F; Bebawy M
Semin Cell Dev Biol; 2015 Apr; 40():35-40. PubMed ID: 25843775
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of microparticles.
van der Heyde HC; Gramaglia I; Combes V; George TC; Grau GE
Methods Mol Biol; 2011; 699():337-54. PubMed ID: 21116991
[TBL] [Abstract][Full Text] [Related]
34. Role of plasminogen activation in neuronal organization and survival.
Ho-Tin-Noé B; Enslen H; Doeuvre L; Corsi JM; Lijnen HR; Anglés-Cano E
Mol Cell Neurosci; 2009 Dec; 42(4):288-95. PubMed ID: 19683575
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of microparticles in DIC and its impact on inflammatory processes.
Rahman S; Cichon M; Hoppensteadt D; Cunanan J; Jeske W; Thethi I; Fareed J
Clin Appl Thromb Hemost; 2011; 17(6):E202-4. PubMed ID: 21422058
[TBL] [Abstract][Full Text] [Related]
36. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
37. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury.
Lijnen HR
Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512
[TBL] [Abstract][Full Text] [Related]
38. Activation of plasminogen by Streptococcus mutans.
Jones MN; Holt RG
Biochem Biophys Res Commun; 2004 Sep; 322(1):37-41. PubMed ID: 15313170
[TBL] [Abstract][Full Text] [Related]
39. The role of plasminogen-plasmin system in cancer.
Kwaan HC; McMahon B
Cancer Treat Res; 2009; 148():43-66. PubMed ID: 19377918
[TBL] [Abstract][Full Text] [Related]
40. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
